Data / Form D filings / MorphImmune Inc.
MorphImmune Inc.: Form D filings
MorphImmune Inc., a health care company in West Lafayette, IN, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on May 17, 2023, reports $15 million sold of a $15 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1281 WIN HENTSCHEL BOULEVARD, SUITE 1300, West Lafayette, IN, 47906
- Phone
- (650) 238-4942
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1911732
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2023 | New notice | $15,000,000 | $15,000,000 | 11 | May 5, 2023 | sec.gov | |
| Feb 17, 2022 | New notice | $19,000,001 | $17,135,765 | $1,864,236 | 18 | Feb 4, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sunil Singhal, M.D. | Director | |
| Philip Low, Ph.D. | Director | |
| Isaac Barchas | Director | |
| Clay B. Siegall, Ph.D. | Executive Officer, Director | |
| Ronald Martell | Director | |
| Franklyn Prendergast, M.D., Ph.D. | Director |
Other health care companies in Indiana that filed recently
- OSSEOLABS, INC. $50,067 · Sep 4, 2026
Every Form D from the week of May 15, 2023 · All recent filings in Indiana · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what MorphImmune Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.